Market Research Blog

According to the latest research by Future Market Insights, HBsAg Testing market is set to witness a 5.9% growth during the year 2021-2031.

The market has been increasing at a gradual rate and is projected to witness lucrative growth due to increase in cirrhosis and liver cancer deaths due to prevalence of hepatitis B, technological advancements in diagnostic kits and due to increase in cirrhosis and growing awareness regarding early detection of hepatitis B.

What is Driving Demand for HBsAg Testing?

Hepatitis B is a potentially fatal infection and has turned into a vital healthcare problem across the world. Rise in prevalence of hepatitis B and need for early detection of hepatitis B are primary factors supporting the market growth.

In addition, rise in awareness among the population; and increase in initiatives by non-profit organizations and governments add to the development of the market. Increase in awareness among the patients’ leads to early detection of the disease. This is driving the demand for HBsAg testing.

Growing research and innovation, rise in healthcare expenditure and urbanization is resulting into rapid adoption of testing procedures, which in turn leads to market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14155

Rising cases of Hepatitis B, likely to increase the HBsAg Testing Sales

Hepatitis B is an infection of worldwide importance, with a projected of 296 million people living the virus globally, according to the data provided by WHO. In the year 2019, hepatitis led to 820 000 deaths, majorly from complications such as cirrhosis and hepatocellular carcinoma.

The occurrence of hepatitis B is highest in the African and Western Pacific regions where 6.1% and 6.2% respectively of the adults are infected. Hepatitis B can lead to chronic infection and show a high risk of mortality. It is projected that 80-90% of the newborns infected with hepatitis B in first year of life suffer from chronic infections.

There is rise in prevalence of hepatitis B also because of the growing urbanization and environmental changes because of the changing lifestyle. These factors create a lucrative opportunities for hepatitis B diagnostic test manufacturers.

US and Canada HBsAg Testing Market Outlook

United States and Canada lead the HBsAg Testing market. The market is likely to witness significant growth owing to the high prevalence of acute cases of hepatitis B, availability of advanced diagnostic tools and rising awareness regarding hepatitis testing.

The rapid growth in the Canadian market is owing to the initiatives of the non-government and organizations. For example, the Public Health Agency of Canada conducted the World Hepatitis Day with the aim of growing awareness regarding hepatitis diagnosis. Thus, resulting into a demand surge for hepatitis diagnosis in the country.

Europe Demand Outlook for HBsAg Testing

Europe is second lucrative market and is likely to register a remarkable growth owing to the rising cases of hepatitis B infections, increasing diagnostic product launches, and growing healthcare expenditure in the region.

As per the World Health Organization, Hepatitis B is a contagious disease that affected approximately 15 million people in 2019 in the WHO European region. The growing geriatric population is also increasing the demand for hepatitis testing as complications associated with hepatitis worsen with aging.

Who are the Key Manufacturers and Suppliers of HBsAg Testing?

Some of the leading manufacturers and suppliers of HBsAg Testing include

• CTK Biotech Inc.
• Biopanda Reagents Ltd.
• Avecon Healthcare Pvt Ltd.
• Abbott
• Bio-Rad Laboratories Inc.
• Siemens Healthineers
• QIAGEN
• F. Hoffmann-La Roche AG and others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14155

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Driven by the demand for efficient medical laboratory equipment and the changing face of healthcare models, the global market for vacuum mixing devices – valued at ~ US$ 154.0 Mn in 2021 – is estimated to grow by ~ 2% YOY in 2022. These insights are according to a new research report by Future Market Insights (FMI), which underlines the key headwinds and tailwinds determining the future potential of vacuum mixing devices market.

The FMI analyst is of the opinion that market gains will further be upheld by the clinical benefits associated with use of vacuum mixing devices. FMI expects the vacuum mixing devices to see unwavering growth in the next 10 years, as the global healthcare space actively embraces ‘efficiency-enabling’ medical mixing equipment.

According to the FMI report, the vacuum mixing devices market reflects a fair degree of fragmentation, wherein a large pool of regional manufacturers is competing neck to neck. Stryker Corporation and Zimmer Biomet remain two of the market goliaths, with strong product portfolios and extended regional presence.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7515

A majority of the revenues of these two companies are generated from the US and Germany, and their focus on strategic collaborations will continue to yield significant profit benefits and ensure sustained growth. For instance, in 2021, Zimmer Biomet Holdings, Inc. – a global leader in musculoskeletal healthcare – collaborated with Apple to transform the patients’ journey for two most common type of surgeries undergone by the Americans every year – knee and hip replacement. This collaboration was aimed at popularizing the Zimmer Biomet ‘mymobility™’ app, an app that makes use of Apple Watch to facilitate constructive connections between patients and their respective surgical teams.

The FMI analyst finds that though the factors conditioning success differ for market players of varying statures, but in all the cases, the market partakers will have to be adept at effective tracking of the evolving market trends and make necessary adaptations.

Portability: The New Normal Grappling End User Appeal

In 2021, the devices with vertical orientation is estimated to surpass other variants and account for over ½ of the global vacuum mixing devices-derived value. Though end users will continue to invest in vertical vacuum mixing devices, the demand for rotational vacuum mixing devices will also see a considerable uptick through 2022, unveils FMI.

With ‘portable’ emerging as the new norm in the medical laboratory equipment space, manufacturers are jumping onto the ‘portability’ bandwagon by launching newer models of vacuum mixing devices that are easy-to-carry and compact in size. According to the FMI analysis, North America (29%) and Europe (26%) will continue to be the leading markets for vacuum mixing devices in 2022 and beyond, set in motion by robust healthcare infrastructure and massive investments in development of high-quality laboratory essentials.

Vacuum mixing devices worth ~ US$ 128 Mn were sold in hospitals in 2021, primarily driven by the growing number of inpatient and outpatient procedures. Manufacturers, to draw upon this increase in demand, are focusing on effective marketing of their products to hospitals by using ‘easy-to-use’ and ‘compatibility with varying viscosities’ as two of their key marketing touchpoints. However, various regulations put in place for manufacturing of vacuum mixing devices will continue to impede its penetration by increasing the ‘time-to-market’ factor.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-7515

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Testosterone Injectable Market Overview

According to the latest research by Future Market Insights, the Testosterone Injectable Market is set to witness a growth of 4.1% CAGR during the year 2021-2031. Testosterone injectable market is one of the most important classes of hormone injectable therapy adopted globally.

Testosterone injectable market is gaining acceptance among patients and physicians due to increasing awareness regarding benefits and efficacy of testosterone replacement therapy products.

The primary male hormone responsible for improving male sexual traits, spermatogenesis, and fertility is testosterone. Erectile dysfunction is caused by a lack of testosterone production, which can be treated with testosterone injectable.

What is Driving Demand for Testosterone Injectable Market?

The demand for testosterone injectable market is largely based on the rise in geriatric population with high risk of testosterone deficiency, growing awareness about testosterone injectable, improved health care infrastructure, policies, and advancement in health care infrastructure. Moreover, access to various diagnostic and treatment services has improved in the recent past, especially in developed economies and this is one of the major factor that has boosted the demand for testosterone injectable market.

The U.S. Testosterone Injectable Market Outlook

The market for testosterone injectable is most prominently driven by countries like U.S. According to a study published in the European Association of Urology Journal, testosterone treatment patterns in the United States have increased by 1.8 to 4-fold in the last two decades.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14052

Moreover, there is an increasing number of people suffering from hypogonadism, growing geriatric population and growing availability of effective and convenient treatment options results in an increasing demand for testosterone injectable in the U.S. The U.S. is undertaking a variety of attempts to strengthen their research and development facilities to fulfil the demand for testosterone injectable.

Europe Demand Outlook for Testosterone Injectable Market

As per a study published in the National Center for Biotechnology Information (NCBI), approximately 30% of men worldwide are affected by hypogonadism. Europe accounts for the existence of numerous medical centers, robust healthcare infrastructure, and increasing government initiative.

Furthermore, rising rise in the incidence of testosterone deficiency, increase in geriatric population with high risk of testosterone deficiency, and increasing awareness about testosterone substitute therapy are the key driving factors in testosterone injectable market in Europe.

Who are the Key Manufacturers and Suppliers of Testosterone Injectable Market?

The key companies working in testosterone injectable and solutions for testosterone injectable are

• Clarus Therapeutics
• Bayer AG
• Endo Pharmaceuticals Inc.
• Eli Lilly Company
• Kyowa Kirin International plc
• Mylan N.V.
• Novartis AG
• and Pfizer Inc.
• J & K Scientific Ltd.
• Beijing Coupling Technology Co.Ltd.
• Longyan Tianhua Biological Technology Co.Ltd

For any queries linked with the report, ask an analyst >>

https://www.futuremarketinsights.com/ask-question/rep-gb-14052

Manufacturers in the market focus on carrying out certain strategic activities such as acquisitions and mergers, expansion, product launch, etc. For instance, on May 25, 2020, Partner Perspectives announced the latest innovation in Testosterone Replacement Therapy (TRT) is JATENZO®, an oral softgel formulation of testosterone undecanoate (TU) for adult males for conditions associated with a deficiency or absence of endogenous testosterone.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Testosterone Injectable Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-14052

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

 

Key Segment

By Dosage Form:

• Hypogonadism
• Autoimmune Conditions
• Genetic Disorders
• Sex Organ Surgeries
• Others

By Drug Active Ingredient:

• Testosterone
• Testosterone Cypionate
• Testosterone Undecanoate
• Testosterone Enanthate
• Methyl testosterone
• Others

By Age Group:

• Adults
• Geriatric
• Paediatric

By End User:

• Hospitals
• Homecare
• Specialty Clinics
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa

For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-14052

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-781

Key Takeaways – Tissue Engineered Skin Substitute Market Study

• With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
• Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
• The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-781

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The global compact construction equipment market is expected to register a CAGR of 3.8% from 2022-2032.

“The compact construction equipment market is projected to see significant changes in the coming years, as players in the market strive to capitalize on the opportunity by expanding their compact equipment operations into potential markets”.

The major players in the mini construction equipment market are approaching the market with new tactics and a more efficient company model. Compact construction equipment’s main advantage is its adaptability and capacity to handle tasks that were previously reserved for large machinery.  The residential and commercial sectors are the primary drivers of the compact construction equipment business.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-53

How is the Global Compact Construction Equipment Market Classified?

“Compact construction equipment trends portends high popularity of wheeled loaders among the other equipment types.”

On the basis of type, the global compact construction equipment market can be divided into track loaders, excavators, backhoe loaders, wheeled loaders, skid steerers, and telehandlers. Among these compact construction equipment trends, sales of wheeled loaders are likely to stay on the high side as they assist in loading, unloading, and bulk material movement at construction sites.

The market can be classified into four categories based on power output: 100 HP, 101–200 HP, 201–400 HP, and >400 HP. On the basis of capacity, the market can be classified into three categories: 5L, 5L-10L, and >10L.

The construction equipment market in North America and Western Europe has been growing steadily. According to the Associated General Contractors of America (AGC), the construction market growth was 3.7 percent in August 2020, owing to an increase in residential building and construction spending. The COVID-19 pandemic has had an influence on non-residential buildings, which could have an impact on construction equipment demand in the region in the near future.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-53

How can Advanced Strategies Help Compact Construction Equipment Manufacturers?

“Mergers and extensions of various compact construction equipment contributors increase the industry’s sales and market worth”.

With the recent strategic supplier agreement between John Deere and Wacker Neuson, both being compact construction equipment contributors, for building compact excavators of John Deere at the factory of Wacker Neuson in China, the compact construction equipment business is expected to grow significantly. The partnership focuses on growing the distribution of compact construction equipment range in Southeast Asia, Oceania, and China.

A similar business extension was carried out by another key market player, JCB North America. A multinational compact construction equipment manufacturing company has made investments to acquire the business of their West Coast dealer, JCB of Southern California, to extend their sales for the customers throughout greater Los Angeles and the neighboring countries.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-53

What Factors are Contributing to the Growth of the Compact Construction Equipment Market?

“Compact size of the construction equipment, growing investments in technology, and rise in construction activities, especially towards smart city projects will contribute to adoption trends of compact construction equipment.”

Compact construction equipment’s main advantage is its adaptability and capacity to handle tasks that were previously reserved for large machinery. Compact construction equipment has several advantages, including low cost, small weight, and ease of transport and operation.

An increasing desire for small size construction equipment, low price, reliability, and increased productivity are the primary factors driving the compact construction equipment market. Compact construction equipment is also growing due to the increasing number of new technology attachments available for compact construction equipment, such as levelers, soil conditioning tools, and trenchers. In addition, private users, such as sundowners or hobby farmers, as well as real estate developers, have played a vital role in the growing usage of compact construction equipment.

The compact construction equipment market has several issues, including fuel price volatility, low entry barriers, and a lack of organization.

The changing trends from pedal operation to the use of joysticks, availability of suspension seats and air conditioners at reasonable prices, is further driving growth in the compact construction equipment market. Another emerging trend is the GPS tracking system in compact equipment, which is a major attraction for rental purchasers, as it helps them safeguard their machinery against theft and track its location when needed. Self-monitoring and auto shutdown are other attractive emerging trends in the compact construction market.

Estimated to exceed the revenues of US$ 588.8 million in 2022, the global market for radiotherapy patient positioning accessories is projected to witness a moderate 4.3% annual growth in revenue, over that in 2021. According to a recent research study of Future Market Insights (FMI), nearly 1/5^th of the overall installed base of radiotherapy patient positioning accessories is accounted by couch tops and overlays, followed by immobilization systems.

More than 40% of the total adoption of radiotherapy patient positioning accessories is registered by hospitals at a global level, as indicated by FMI’s report. A higher rate of demand for radiotherapy patient positioning accessories is likely to be recorded by cancer research institutes and radiation therapy/proton therapy centers, in the forthcoming years.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-9325

Government Support Pivotal in Accelerating Installation of Radiotherapy Patient Positioning Accessories

North America and Europe currently hold a combined revenue share of over 60% in the global radiotherapy patient positioning accessories market. Remarkable increase in the rate of early cancer diagnosis is leading to hike in the adoption of radiotherapy, more prominently in developed countries such as the US, UK, and Germany among others. Moreover, the study opines that the increasing awareness about multiple types of cancers, further backed by favorable government initiatives regarding cancer diagnosis and treatment, will be one of the strongest factors pushing penetration of radiotherapy patient positioning accessories within developed regional markets.

On the other side, governments of several developing economies are also extending support and investments in the cancer diagnosis and treatment space, particularly through screening camps – which is boosting the diagnosis rates of cancer. This according to the report is majorly responsible for promising growth in the installed base of radiotherapy systems and patient positioning accessories. According to FMI’s analysis, the flourishing medical tourism sector is also registering significant contribution to the thriving demand for radiotherapy patient positioning accessories in emerging economies.

Strategic Efforts in Stronger Distribution Network Gathering Momentum among Manufacturers

Some of the key players actively competing in the radiotherapy patient positioning accessories market include Bionix Radiation Therapy, CDR Systems, CIVCO Radiation, Orfit Industries N.V., IZI Medical Products, Klarity Medical Products, Qfix, Elekta AB, and Eckert & Ziegler BEBIG, among others. Several leading manufactures are focused on the development and approval of new products. CIVCO Radiotherapy announced the FDA clearance and CE mark for their Solstice SRS Immobilisation System, in the H2 2021.

Strong distribution partnerships tend to result in effective product reach across the value chain and thereby supports the business growth. While the growing trend of strategic distribution partnerships between peer companies operating in the radiotherapy patient positioning accessories market is translating into improved product outreach, FMI’s analysis suggests that collaborative activities in terms of distribution of radiotherapy patient positioning accessories will particularly benefit smaller players in the market. Recently, POLL Medical entered the partnership with CIVCO for the global distribution of CE-marked GrayDuck Stents.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-9325

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The rise in installation of radiation therapy machines to treat a wide range of cancers further uplifts the probability of radiation toxicity in cancer patients. Future Market Insights (FMI), in its new study on the global radiation toxicity treatment market, foresees that the market will reach the value of US$ 5.5 Bn by the end of forecast period (2022 – 2029) and further experience a major upturn post 2029.

Installed base of internal radiation therapy machines has tremendously increased over the past decade. Improving reimbursement scenario and favorable government policy framework in the field of cancer care are adding to the accessibility of radiation therapy, thereby favoring the growth of radiation toxicity treatment market.

The study suggests that notable players in Asia Pacific will continue to invest heavily in the development of new radiation therapies, in line with the increasing cancer prevalence and improving rate of diagnosis in the region.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10724

Key Takeaways – Radiation Toxicity Treatment Market Study

• Increasing adoption of colony stimulating factors such as Neulasta from Amgen will account for more than 75% of revenue share in the radiation toxicity treatment market through 2029 end.
• Attributed to high incidences of radiation toxicity due to emission of gamma radiation from positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scanners installed at hospitals and diagnostic centers, non-ionizing radiation is also set to offer lucrative opportunity to market participants.
• North America continues to lead its way in the radiation toxicity treatment market, while South Asia is foreseen to grow at a significant rate in the near future.

Who Is Winning?

Some of the key players operating in the radiation toxicity treatment market include Amgen Inc., Partner Therapeutics, Mylan N.V., and Novartis AG. Leading players of the radiation toxicity treatment market are focusing on acquiring smaller companies to enhance their product portfolio and improve regional market positioning.

For instance, Siegfried Group announced the acquisition of drug product manufacturing facility together with all related employees and contracts from Arena Pharmaceuticals GmbH in Zofingen, Switzerland. Also, in 2018, Partner Therapeutics (PTx) acquired global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10724

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Implantable drug-eluting devices are playing a key role in the management and treatment of various chronic disorders, particularly cardiovascular diseases. Advancements in micro and nanotechnology are aiding key manufacturers to design novel implantable drug-eluting devices.

Moreover, controlled and site-specific attributes of implantable drug-eluting devices, further complemented by compatibility with the targeted drug delivery, are relieving the burden of complex dosing schedule and systemic toxicity of conventional drug delivery system. The global implantable drug-eluting devices market is projected to cross the US$ 10 Bn mark towards the end of 2022. Market leaders in implantable drug-eluting devices landscape are maintaining their focus on refining manufacturing processes.

Remote-Controlled Chips and Programmable Devices – Future of Targeted Drug Delivery

Increasing clinical trials and research & development of remote-controlled and programmable drug-eluting devices

Massachusetts Institute of Technology (MIT) researchers have developed a remote-controlled contraceptive hormone (levonorgestrel) delivery chip implant, which can turn the device on and off.

Implantable drug-eluting devices allow minimum effective doses and support oral opioid weaning

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-10671

Implantable drug-eluting devices such as SynchroMed II intrathecal drug delivery system with controlled workflow system, plays an effective role in reducing or eliminate the use of oral opioids.

Antiretroviral (ARV) drug implant is expected to emerge as a promising approach for HIV treatment and prevention

In July 2022, Merck & Co. started the development of slow-release antiretroviral (ARV) drug implant as a promising approach for HIV treatment.

Medical-Pharma Collaborating to Balance Demand and Supply

A comprehensive view of the implantable drug-eluting devices market has led our analysts to conclude that, the market is expected to grow with an impressive rate. This market growth is mainly attributed due to increasing innovations and developments in implantable drug-eluting devices for the management and treatment of breast cancer, schizophrenia, Parkinson’s disease, and photosensitivity diseases. Besides, FMI analyst suggests that markets in North America and Europe are expected to hold major value shares in global implantable drug-eluting devices landscape. To cater to rising demand for implantable drug-eluting devices, medical device companies are collaborating with pharmaceutical companies for the development of efficient drug delivery devices.

Increasing use of syringe-based subcutaneous implantable drug-eluting devices is anticipated to minimize the number of invasive surgical procedures. Introduction of implantable drug-eluting devices or rare conditions such as central precocious puberty (CPP) will emerge as an important factor shaping the market for implantable drug-eluting devices.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-10671

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Weighing equipment is the instrument used to measure the weight of a product. Industrial weighing equipment is used to measure the weight of various products such as instruments, chemicals, and machines in industries. Industrial weighing equipment is present everywhere in the industry from the initial stage that is raw materials stage to the final stage, distribution of finished products, and its applications across a wide range of industries will continue to uphold demand for the product, ultimately boosting the growth of the global market for industrial weighing equipment.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-294

Advancements in next-gen technologies have been triggering paradigm shifts in the integral designs of industrial weighing equipment for years, and the trend is likely to persist in the coming future. Leading manufacturers are continually introducing innovative features by integrating advanced weighing technologies such as process weighing technology, and other popular technologies such as the Internet of Things (IoT) and Artificial Intelligence, to make today’s industrial weighing equipment smarter.

COMPETITIVE LANDSCAPE

• Avery Weigh-Tronix
• RADWAG WagiElektroniczne
• CI Precision Ltd.
• A&D Weighing
• Atrax Group NZ Ltd,
• Avery Weigh-Tronix.
• Thompson Scale Company
• Eastleigh Limited
• Bilwinco AS
• D Brash &Sons Ltd
• Sartorius AG Ohaus Corporation
• Maguire Products Inc.
• Mettler Toledo International Inc.

The global market for industrial weighing equipment is highly fragmented as the number of smaller companies entering the market is increasing. Nevertheless, leading manufacturers, as well as small industry players, are concentrating on offering utmost levels of accuracy through innovative features, and modifying their strategies to sync with the changing business environments.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-294

REGION-WISE ANALYSIS

The industrial weighing equipment market is geographically segmented into seven key regions which are, North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Asia Pacific is anticipated to be the fastest-growing industrial weighing equipment market with a CAGR expected to be around 6% in the coming years. In the region, the demand is mainly triggered by increasing applications of weighing technologies in many industrial activities, and thereby, industrial growth is among the biggest drivers of growth for the market in the Asia Pacific.

Sales are also likely to remain healthy in the North American region, as manufacturers are introducing next-generation and technologically advanced ranges of their products under the category of industrial weighing equipment. Tightening quality standards and safety regulations are triggering the adoption of highly accurate and high precision weighing equipment in the industrial setup across the region, and this will incur the trend of product innovation in the industrial weighing equipment market in the Americas.

REGION-WISE ANALYSIS

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
• East Asia (China, Japan, South Korea)
• South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
• Oceania (Australia, New Zealand)
• Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-294

SEGMENT ANALYSIS

The industrial weighing equipment market can be segmented based on the following: